Jejunoileal Crohn's disease: A case-control study

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 2, 2004, Pages 160-166

  Higuero, Thierry ^a   Merle, Corinne ^a   Thiéfin, Gérard ^a   Coussinet, Sylvie ^a   Jolly, Damien ^a   Diebold, Marie Danièle ^a   Zeitoun, Paul ^a   Cadiot, Guillaume ^a,b  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; STEROID;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; DUODENUM OBSTRUCTION; ESOPHAGUS OBSTRUCTION; FEMALE; FOLLOW UP; HUMAN; ILEOJEJUNITIS; ILEUM DISEASE; JEJUNUM DISEASE; MALE; MALNUTRITION; RETROSPECTIVE STUDY; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE RESECTION; STOMACH OBSTRUCTION; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; VOMITING;

EID: 1642293898     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(04)94871-3     Document Type: Article

References (40)

1. Sachard DB, Andrews H, Farmer RG, Pallone F, Pene AS, Prantera C, et al. Proposed classification of patients subgroups in Crohn's disease. Working team report 4. Gastroenterol Int 1992;5:141-54.
2. Polito JM, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996;111:580-6.
3. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985;88:1818-25.
4. Crohn BB, Yunich AM. Ileojejunitis. Ann Surg 1941;113:371-80.
5. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993;105:1716-23.
6. Tan WC, Allan RN. Diffuse jejunoileitis of Crohn's disease. Gut 1993;34:1374-8.
7. Touze I, Gower-Rousseau C, Grandbastien B, Paris JC, Quandalle P, Cortot A, et al. Maladie de Crohn jéjuno-iléale diffuse; une forme particulière de la maladie? Gastroenterol Clin Biol 1999;23:307-11.
8. Gower-Rousseau C, Salomez JL, Dupas JL, Marti R, Nuttens MC, Votte A, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994;35:1433-8.
9. Gollop JH, Phillips SF, Melton LJ, III, Zinsmeister AR. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut 1988;29:49-56.
10. Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease. Am J Gastroenterol 1997;92:1467-71.
11. Goldstein F, Abramson J, Messori DA, Szydlowski T. Thornton JJ, III. Diagnosis and treatment of diffuse ileojejunitis. Am J Gastroenterol 1977;68:465-9.
12. Andant C, Godeberge B, Chaussade S, Dupas JL, Soulé JC. Aspects cliniques et évolutifs de la maladie de Crohn duodéno-jé junale symptomatique. Gastroenterol Clin Biol 1999;23:1134-8.
13. Besnard M, Jaby O, Mougenot JF. Ferkdadji L. Debrun A, Faure C, et al. Postoperative outcome of Crohn's disease in 30 children. Gut 1998;43:634-8.
14. Harper PC, McAuliffe TL, Beeken WL. Crohn's disease in the elderly. A statistical comparison with younger patients matched for sex and duration of disease. Arch Intern Med 1986;146:753-5.
15. Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 1988;95:1523-7.
16. Alic M. Workforce composition and the sex ratio of Crohn's disease incidence. Am J Gastroenterol 1999;94:3652-3.
17. Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 2000;12:31-8.
18. Colombel JF, Dupas JL, Cortot A, Salomez JL, Marti R, Gower-Rousseau C, et al. Incidence des maladies inflammatoires du tube digestif dans la Région Nord-Pas de Calais et le département de la Somme (1988). Gastroenterol Clin Biol 1990;14:614-8.
19. Loftus EV, Jr., Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998;114:1161-8.
20. Mekhjian HS, Switz DM, Melnyk CS, Rankin GB, Brooks RK. Clinical features and natural history of Crohn's disease. Gastroenterology 1979;77:898-906.
21. Modigliani R, Colombel JF, Dupas JL, Dapoigny M, Costil V, Veyrac M, et al. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology 1996;110:688-93.
22. Persson PG, Bernell O, Leijonmarck CE, Farahmand BY, Hellers G, Ahlbom A. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 1996;110:1339-45.
23. Silverstein MD, Loftus EV, Sandborn WJ, Tremaine WJ, Feagan BG, Nietert PJ, et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology 1999;117:49-57.
24. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996;110:424-31.
25. Reif S, Lavy A, Keter D, Fich A, Eliakim R, Halak A, et al. Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am J Gastroenterol 2000;95:474-8.
26. Heresbach D, Heresbach-Le Berre N, Ramee MP, Semana G, Gosselin M, Bretagne JF. Fréquence et valeur pronostique du granulome épithélioïde au cours des maladies inflammatoires chroniques de l'intestin. Gastroenterol Clin Biol 1999;23:1376-87.
27. Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988;29:588-92.
28. Hamon JF, Carbonnel F, Beaugerie L, Sezeur A, Gallot D, Malafosse M, et al. Comparaison de l'évolution à long terme des maladies de Crohn perforantes et non perforantes. Gastroenterol Clin Biol 1998;22:601-6.
29. Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology 1998;115:259-67.
30. Michelassi F, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn's disease. Experience with 1379 patients. Ann Surg 1991;214:230-8.
31. Korelitz B, Hanauer S, Rutgeerts D, Present D, Peppecorn M. Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: a 2 year multicenter trial (abstract). Gastroenterology 1998;114:A1011
32. Lemann M, Cuillerier E, Bouhnick Y. Azathioprine for prevention of Crohn's recurrence after ileal or colonic resection (abstract). Gastroenterolgy 1996;110:A948.
33. Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995;37:674-8.
34. Ewe K, Press AG, Singe CC, Stufler M, Ueberschaer B, Hommel G, et al. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. Gastroenterology 1993;105:367-72.
35. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995;123:132-42.
36. Bouhnik Y, Lemann M, Mary JY, Scemama G, Tai R, Matuchansky C, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996;347:215-9.
37. Lemann M, Bonhomme P, Bitoun A, Messing B, Modigliani R, Rambaud JC. Traitement de la maladie de Crohn par l'azathioprine ou la 6-mercaptopurine. Etude rétrospective chez 126 malades. Gastroenterol Clin Biol 1990;14:548-54.
38. Lapidus A, Bernell O, Hellers G, Lofberg R. Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology 1998;114:1151-60.
39. Jahnsen J, Moum B, Schulz T, Sauar J, Lygren I, Stray N, et al. Inflammatory bowel disease, disease course and status 5 years after diagnosis (abstract). Gastroenterology 2000;118:A118.
40. Etienney I, Gendre JP, Bouhnick Y, Lemann M, Cosnes J, Modigliani R, et al. La maladie de Crohn 20 ans après le diagnostic (abstract). Gastroenterol Clin Biol 1999;23:A87.